Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the development of therapeutics for a range of cancer indications. The Company's product candidates are galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1 (WT1), antigen, and SLS009, a selective small molecule cyclin-dependent kinase 9 (CDK9) inhibitor. GPS is a cancer immunotherapeutic agent licensed by Memorial Sloan Kettering Cancer Center (MSK), that targets the WT1 protein, which is present in an array of tumor types. GPS has potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic malignancies and solid tumor indications. The Company is developing SLS009, which is licensed by GenFleet Therapeutics (Shanghai), Inc., for all therapeutic and diagnostic uses in the world outside of mainland China, Hong Kong, Macau, and Taiwan.
Find out what a historical investment in Sellas Life Sciences Group Inc would be worth today using our SLS stock calculator.
Buying SLS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Sellas Life Sciences Group Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in SLS
What is the ticker symbol of Sellas Life Sciences Group Inc?
The ticker symbol for Sellas Life Sciences Group Inc is SLS.
How much is one share of SLS?
One share of SLS is valued at $14.86 as of 20 November 2026.
What is the market capitalisation of Sellas Life Sciences Group Inc SLS?
As of 20 November 2026 Sellas Life Sciences Group Inc has a market cap of $3.66B.
What is the 52-week high for Sellas Life Sciences Group Inc stock?
The Sellas Life Sciences Group Inc 52-week high stock price is $24.89.
What is the 52-week low for Sellas Life Sciences Group Inc stock?
The Sellas Life Sciences Group Inc 52-week low stock price is $1.39.
Can I buy SLS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SLS shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SLS on Stake
Buy SLS from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of SLS from only US$10 with fractional shares